ew treatment for cardiac abnormalities in cirrhosis
Not Applicable
Completed
- Conditions
- Health Condition 1: null- Acute-on-chronic Liver Failure During Systemic Inflammatory Response (SIRS) and SepsisHealth Condition 2: K746- Other and unspecified cirrhosis ofliver
- Registration Number
- CTRI/2018/02/012230
- Lead Sponsor
- Institute of liver and Biliary Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 114
Inclusion Criteria
1)Age 18-65 years
2)ACLF (Acute on Chronic Liver Failure), as diagnosed by APASL (Asian Pacific association of Study of Liver Disease) criteria mentioned above.
Exclusion Criteria
1)Patients with evidence of sepsis at presentation.
2)Current therapy: Recent blood or blood component transfusion in the last 2 days.
3)HIV positive/ AIDS patients
4)Patients requiring anti platelet therapy,
5)Renal insufficiency requiring dialysis
6)Active malignancy within the last 5 years
7)Patient with other neurological disease and metabolic disorders, unbalanced heart failure and/or respiratory failure or end-stage renal disease
8)Administration of anticoagulants, antifibrinolytics,
9)Not willing to participate in the study
Pregnancy
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method